Bitcoin Socialpreneur offers Free COVID-19 Testing for families at the San Mateo Marriott Hotel

Hispanics and African-American families suffer twice the death toll and five times the hospitalization due to COVID-19

What Frank creates is amazing, he cares deeply about helping marginalized communities”

— Dana Hee, Olympic Gold Medalist & Author

SAN MATEO , CALIFORNIA, UNITED STATES, December 3, 2020 /EINPresswire.com/ — When Frank Lee, the founder and CEO of Virus Geeks Inc. learnt about Hispanics and African-Americans suffering twice the mortality rate and five times the hospitalization, Frank began working on the first initiative of its kind to help migrant farmers in Watsonville, CA gain access to COVID-19 testing.

Weekly testing is crucial to mitigate the spread of the Virus. The sooner we learn of an infection rather than wait for someone to report an infection, better the chance to flatten the curve, and get things back to normal. The new Cal/ OSHA COVID-19 testing standard makes sense because it a unified approach requiring businesses to be responsible in how they will manage infections and provide needed COVID-19 testing and related healthcare services to their employees. Because of the data reporting requirements to the health departments, businesses can no longer look the other way when there’s an infection; one agency will notice.

“COVID-19 is a socio-economic problem throughout California. Most counties are in the purple tier, business are facing the threat of hard shut down, but the hidden travesty are the rural communities – they are what I am the most concerned about.” “In San Francisco, the wait is so long to get a COVID-19 test, I watched people with challenges such as non-English speakers sent away at a popular testing site by the pier.

That’s when Frank, Pauline Cheung of the San Mateo Chamber of Commerce, and San Mateo Marriott General Manager, Chris Holbrook partnered together to offer COVID-19 testing free to the public. It’s amazing how much the local businesses and the community are embracing having a COVID-19 test site in the neighborhood. “They want to know someone cares enough to notice, people are thanking us all day for our services, and we appreciate the gesture,” says Frank.

Testing is free if you have insurance, and federal funds will be used for those not insured. PCR (nasal swab) testing is the Gold standard approved by the FDA, CDC, all health departments, and organizations.

Virus Geeks is at the San Mateo Marriott at 1770 S Amphlett Blvd, San Mateo, CA – make a right turn at the entrance and follow the road to the two red tents. Appointments are available online at https://my.virusgeeks.com/gettested or you can get tested without one. Best part, wait time is three minutes.

Portion of the proceeds from each test goes towards helping families struggling with the pandemic.

Frank Lee
Virus Geeks Inc
4084440040 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Global Pharma Market 2020 Industry Analysis, Size, Share, Growth, Trends & Forecast To 2026

New Study Reports “Pharma Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, December 3, 2020 /EINPresswire.com/ — Pharma Market 2020-2026

New Study Reports “Pharma Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports.

Report Summary:-

The Global Pharma Market Report 2020-2026 (Forecast Period) Offers An In-Depth Study Of Market Growth Factors, Future Evaluation, Country-Level Analysis, Pharma Market Distribution, And Competitive Landscape Study Of Significant Industry Players. Every Segment Of The Global Pharma Market Is Extensively Assessed In The Research Report. The Segment Analysis Offers Critical Opportunities Available In The Global Pharma Market Through Leading Segments. The Regional Study Of The Global Pharma Market Helps Readers To Attain A Thorough Understanding Of The Developments Of The Different Geographic Markets In Recent Years And Also Going Forth. In Addition, The Report Provides A Comprehensive Overview Of The Vital Dynamics Of The Global Pharma Market, Including Market Influence And Market Effect Factors, Drivers, Threats, Constraints, Trends, And Prospects. The Research Study Also Contains Other Forms Of Analysis, Such As Qualitative And Quantitative.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Pharma industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Pharma market can be split based on product types, major applications, and important countries as follows:

Key players in the global Pharma market covered in Chapter 12:
Grundfos
Ebara
FLOWSERVE
Argal
Wilo
ITT
HCP
PharmaProduct Manufacturing
Pentair
KSB

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/6073575-covid-19-outbreak-global-pharma-industry-market-report

Market Dynamics:-

The report also examines the several volume trends, the pricing history, and the market value in addition to understanding the key dynamics of the Pharma market. Several future growth drivers, challenges, and opportunities are also analyzed to obtain a better view of the industry.

In Chapter 4 and 14.1, on the basis of types, the Pharma market from 2015 to 2025 is primarily split into:
Precision Treatment
Pump Solutions
Other

In Chapter 5 and 14.2, on the basis of applications, the Pharma market from 2015 to 2025 covers:
Pharmaceutical Company
Research Institute
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Ask Any Query @ https://www.wiseguyreports.com/enquiry/6073575-covid-19-outbreak-global-pharma-industry-market-report

If you have any special requirements, please let us know and we will offer you the report as you want.

Major Key Points from Table of Content:

1 Pharma Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Pharma
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Pharma industry
1.4 Methodology of The Study
1.5 Research Data Source

……

12 Competitive Landscape
12.1 Grundfos
12.1.1 Grundfos Basic Information
12.1.2 Pharma Product Introduction
12.1.3 Grundfos Production, Value, Price, Gross Margin 2015-2020
12.2 Ebara
12.2.1 Ebara Basic Information
12.2.2 Pharma Product Introduction
12.2.3 Ebara Production, Value, Price, Gross Margin 2015-2020
12.3 FLOWSERVE
12.3.1 FLOWSERVE Basic Information
12.3.2 Pharma Product Introduction
12.3.3 FLOWSERVE Production, Value, Price, Gross Margin 2015-2020
12.4 Argal
12.4.1 Argal Basic Information
12.4.2 Pharma Product Introduction
12.4.3 Argal Production, Value, Price, Gross Margin 2015-2020
12.5 Wilo
12.5.1 Wilo Basic Information
12.5.2 Pharma Product Introduction
12.5.3 Wilo Production, Value, Price, Gross Margin 2015-2020
12.6 ITT
12.6.1 ITT Basic Information
12.6.2 Pharma Product Introduction
12.6.3 ITT Production, Value, Price, Gross Margin 2015-2020
12.7 HCP
12.7.1 HCP Basic Information
12.7.2 Pharma Product Introduction
12.7.3 HCP Production, Value, Price, Gross Margin 2015-2020
12.8 PharmaProduct Manufacturing
12.8.1 PharmaProduct Manufacturing Basic Information
12.8.2 Pharma Product Introduction
12.8.3 PharmaProduct Manufacturing Production, Value, Price, Gross Margin 2015-2020
12.9 Pentair
12.9.1 Pentair Basic Information
12.9.2 Pharma Product Introduction
12.9.3 Pentair Production, Value, Price, Gross Margin 2015-2020
12.10 KSB
12.10.1 KSB Basic Information
12.10.2 Pharma Product Introduction
12.10.3 KSB Production, Value, Price, Gross Margin 2015-2020

Continued…..

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Contact US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire

Oxford Nanopore announces single-read accuracy of 99.1% & sequencing a record 10 Tb of DNA in a single PromethION run

OXFORD, OXFORDSHIRE, UNITED KINGDOM, December 3, 2020 /EINPresswire.com/ — Advances are announced as part of broad technology update at the Nanopore Community meeting

During an update at the 2020 Nanopore Community Meeting, Oxford Nanopore revealed a number of key advances in its sequencing technology. These include the release of new improvements in PromethION flow cells that have enabled a new 10 Terabase sequencing record, modal single-read accuracy of 99.1% using a new sequencing chemistry currently in development, high accuracy variant calling tools and automation options for nanopore sequencing experiments at any scale.

Further accuracy improvements

A new analysis algorithm, Bonito CRF, was recently released by Oxford Nanopore, that provides increased accuracy single read basecalling – the process of identifying the sequence of bases on an individual molecule of DNA. This latest update to Bonito builds on previous work to deliver improved performance, and is trained with a larger, more diverse data set. Using Bonito CRF, Oxford Nanopore has shown 98.3% single read accuracy on the current chemistry, and nanopore customers have also reported >98% single read accuracy.

High single read accuracy supports very high consensus accuracy (where a molecule is sequenced multiple times); optimised analysis tools including Guppy/Bonito basecalling, assembly with Canu/Flye and polishing with Medaka, can now enable Q45 with R9.4.1 flow cells and Q50 with R10.3 flow cells.

Variant calling performance is also improving with the latest releases; structural variation (SV) accuracy has reached gold standard of 96% with 30X rather than 60X coverage. SNP accuracy is now at 99.92%, which is comparable to short read accuracy.

In addition, this week Oxford Nanopore has generated modal raw-read accuracy of 99.1% (99%=Q20) using a new chemistry with Bonito, delivered on internal validation sets with a substantial fraction of these raw reads above Q20.

A new yield record

In November, Oxford Nanopore started to ship PromethION flow cells that incorporated a number of iterative improvements in yields and consistency. These improvements have culminated in a 10 Tb internal run using all 48 Flow Cells, a 25% improvement on the previous record. The median output per Flow Cell in this run was 208 Gb — the equivalent of two human genomes over 30X coverage. This success has been reflected in customer data, with increasing yields reported across a range of applications.

Further improvements on the PromethION platform are expected with the release of R10.3 PromethION flow cells in the coming weeks.

Automated sample preparation, at scale

As the number of users of nanopore sequencing in production-scale environments increases, Oxford Nanopore has been focusing during 2020 on automation solutions that enable users to run high numbers of samples, to run larger projects, or simply to automate everyday workflows.

Oxford Nanopore is collaborating with Hamilton to combine expertise to automate library preparation workflows on Hamilton’s NGS STAR 96. The first protocol released through the collaboration enables preparation of 96 samples in under 5 hours, with only one hour of hands-on time. One run fills two PromethION 48s, enabling high yield, highly validated sample prep and sequencing output.

Oxford Nanopore is also working with Opentrons to deliver mid-range lab automation that is suitable for users running the MinION or GridION devices. Opentrons automation liquid handlers are accessible, compact, and can support 2,500 LamPORE tests a day or automation of the Ligation kit, and ARTIC native barcoding method, as well as being suitable for future PCR based applications.

On the small scale level VolTRAX has seen a number of developments this year, including the development of a PCR-ready cartridge design which will be available soon, alongside the existing Sequencing and Multiplex Kits.

Watch the full talk to find out more

Sarah Foxton
Oxford Nanopore Technologies
media@nanoporetech.com
Visit us on social media:
Twitter


Source: EIN Presswire

Small-molecule Drugs and Their Future

Smolecule - Provider of Small Molecules

Smolecule

AUSTIN, TEXAS, UNITED STATES, December 3, 2020 /EINPresswire.com/ — Small-molecule (smolecule) drugs are defined as compounds with a low molecular weight that are capable of modulating biochemical processes to diagnose, treat, or prevent diseases. Small-molecule drugs include aspirin, diphenhydramine, and other molecules that we typically have in our medicine cabinets. Pharmacology usually restricts the term "small-molecule" to molecules that bind specific biological macromolecules and act as an effector, altering the activity or function of the target. Small molecules can have a variety of biological functions or applications, serving as cell signaling molecules, drugs in medicine, pesticides in farming, and in many other roles.

Small-molecule drugs, including natural products, have been the pillars of traditional medicine and played an important role in shaping the world we live in. A classic example is the wonder drug penicillin, which successfully reduced the death rate by bacterial-related pneumonia to less than 1% during World War II. Moreover, small molecules have been some of the biggest blockbusters in the history of the pharmaceutical industry. For example, atorvastatin (Lipitor) generated at least 9 billion dollars per year in revenue for Pfizer during its patent life from 2003–2011. Despite the emergence of many biologics, small-molecule drugs still remain highly prevalent on the latest WHO Model List of Essential Medicines in 2017.

The upper molecular-weight limit for a small molecule is approximately 900 Daltons, which allows for the possibility to rapidly diffuse across cell membranes so that it can reach intracellular sites of action. This molecular weight cutoff is also a necessary but insufficient condition for oral bioavailability as it allows for transcellular transport through intestinal epithelial cells. In addition to intestinal permeability, the molecule must also possess a reasonably rapid rate of dissolution into the water and adequate water solubility, and moderate to low first-pass metabolism.

To healthcare providers and patients, small-molecule drugs are attractive for several reasons. First, because of their relatively low molecular weight and simple chemical structures, their pharmacokinetics and pharmacodynamics are normally more predictable than those of biologics, which often lead to simpler dosing protocols. Second, the development of small-molecule drugs often involves simpler manufacturing, characterizing, and regulatory processes. Additionally, many small molecules are highly stable and orally bioavailable, which further enhances patient compliance. Ultimately, because of all these reasons, small-molecule drugs are naturally relatively more affordable for patients and reimbursement bodies.

Rooney Belous
Smolecule Inc.
email us here


Source: EIN Presswire

HTEC Group Acquires Execom to Further Boost Its Rapid Growth

SAN FRANCISCO, CALIFORNIA, USA, December 3, 2020 /EINPresswire.com/ — – HTEC Group has acquired Execom, a Serbia-based software engineering company with a rich and diverse project portfolio.
– The acquisition supports HTEC’s ambitious growth plans through an expansion of its technical capacities, domain expertise, and market presence.
– HTC Group has also established a presence in Minnesota, one of the largest strategic hubs for MedTech in the US.

HTEC Group, a consulting and technology R&D services company headquartered in San Francisco with offices in Scandinavia, the Netherlands, and the UK, as well as large development centers in Serbia and Bosnia & Herzegovina, has entered the new stage of rapid growth through the acquisition of Serbia-based software engineering company Execom and establishing a presence in new geographies.

The company has enjoyed a steady period of growth throughout recent years, having been recognized by Deloitte as one of the ten fastest-growing companies in Central Europe for three years in a row, with more than double annual growth year on year. Due to the growing need for its sophisticated digital transformation and tech consultancy services, the company could no longer support the demand through organic growth alone. In order to satisfy the demands of the rapidly evolving business landscape, HTEC Group has chosen acquisition as a model for accelerated expansion.

The acquisition of Execom
HTEC Group has chosen to acquire Execom due to the alignment of technical and domain expertise, market presence, and a people-first culture shared by the two companies.

Execom is a software engineering and consultancy company based in Novi Sad, Serbia. Founded in 1995, the company has spent more than two decades building a rich international portfolio of clients and projects across a variety of industries. Similar to HTEC, the company has founded its success on seamlessly integrating with partner organizations and working with them to provide an ideal technological platform for their future growth.

The acquisition further expands HTEC’s substantial resources with close to two hundred highly-skilled engineers, as well as vast experience and know-how in a broad range of industries within the company’s strategic scope. The acquisition establishes HTEC Group as a bona fide consulting and engineering services powerhouse with its expertise spanning diverse industry verticals such as HighTech & Software, MedTech & HealthTech, Transport Tech & Smart Mobility, RetailTech & Distribution, FinTech & Banking, MediaTech & Entertainment, GreenTech & Energy, LabTech & Science Tech, and beyond.

With the acquisition, supplemented by its dynamic ongoing organic growth (even without the acquisition, the company has grown by more than 150 new employees in 2020), HTEC Group stands ready as a digital transformation partner for companies looking to future-proof their business.

Establishment of the Minnesota office
Aside from the expansion of its inner capacities, the company is actively pursuing a presence in new geographies in order to bring its sophisticated technological services closer to relevant industries. The most recent step in this initiative is the establishment of an HTEC office in Minnesota, a regional stronghold for MedTech & Retail with a vibrant startup community.

With these recent steps, HTEC Group firmly states its ambition to become a global leader in enabling the digital transformation of innovative, forward-thinking businesses aiming to address the expectations of the modern markets and clientele. The company will continue to pursue new opportunities for growth, both within its own ranks and through partnerships with organizations recognizing its vision of accelerating businesses through technological excellence.

About HTEC Group:
HTEC Group is a consulting and technology R&D services company headquartered in San Francisco with offices in Scandinavia, the Netherlands, the UK, Serbia, and Bosnia & Herzegovina.

HTEC brings together leading technology experts, creative thinkers, business consultants, and over 500 engineers skilled in product development, hardware and firmware engineering, data science, artificial intelligence, and scalable cloud platforms to deliver fully integrated solutions. The company provides technology solutions in support of demanding corporate clients looking to accelerate their business through digitalizing operations, modernizing legacy technology, and developing new products and services.

Through partnerships with leading scientific research organizations, global corporate customers, as well as some of the most disruptive startups, HTEC Group is engaged in the development of products used by millions all over the world.

Jovana Milankovic Osterday
HTEC Group
email us here
Visit us on social media:
LinkedIn


Source: EIN Presswire

Inhibition of PDK1 Can Reverse Cell Aging

VulcanChem – Global Leading Supplier of Research Chemicals

VulcanChem – Global Leading Supplier of Research Chemicals

A study provides insight into the complex mechanism of cellular senescence and presents a potential therapeutic strategy for reducing age-related diseases.

NEW YORK, NEW YORK, UNITED STATES, December 3, 2020 /EINPresswire.com/ — Recent studies showed that cellular senescence, previously considered an irreversible biological phenomenon, may represent a reversible state, but the mechanism for the reversion is not well elucidated. Last month, Research findings by a Korean team provide insight into the complex mechanism of cellular senescence and present a potential therapeutic strategy for reducing age-related diseases associated with the accumulation of senescent cells.

To identify targets the inhibition of which would convert senescent cells into quiescent cells, the researchers constructed a molecular regulatory network model of cellular senescence. From ensemble analysis of network models, they identified 3-phosphoinositide–dependent protein kinase 1 (PDK1) as a promising target for inhibitors to convert the senescent state to the quiescent state. The researchers validated this prediction in experiments with human dermal fibroblasts, which showed that PDK1 inhibition eradicates senescence hallmarks by suppressing both nuclear factor κB and mTOR signaling through the inactivation of a positive feedback loop composed of PDK1, AKT, IKBKB, and PTEN, resulting in restored skin regeneration capacity. The findings were published in the Proceedings of the National Academy of Sciences.

According to experts at VulcanChem, PDPK1 is a master kinase, which is crucial for the activation of AKT/PKB and many other AGC kinases including PKC, S6K, SGK. An important role for PDPK1 is in the signaling pathways activated by several growth factors and hormones including insulin signaling. Inhibitors of PDK1 inhibitors include BX795, BX912, etc.

"Our research opens the door for a new generation that perceives aging as a reversible biological phenomenon," says Professor Kwang-Hyun Cho of the Department of Bio and Brain Engineering at the Korea Advanced Institute of Science and Technology (KAIST), who led the research with colleagues from KAIST and Amorepacific Corporation in Korea. The scientists recommend investigations are next done in organs and organisms to determine the full effect of PDK1 inhibition. Since the gene that codes for PDK1 is overexpressed in some cancers, the scientists expect that inhibiting it will have both anti-aging and anti-cancer effects.

“The study showed the potential for reverse the aging process, which has been recognized as an irreversible phenomenon in life,” Professor Cho said. “This research marked the beginning of a new era that can prevent diseases related to aging and prolong life span.”

Valerie Walters
VulcanChem
email us here
Visit us on social media:
Twitter


Source: EIN Presswire

Personal Protective Equipment (PPE) Market To 2025 –Global Market Size, Development Status, Top Manufacturers,Forecasts

PUNE, MAHARASTRA, INDIA, December 3, 2020 /EINPresswire.com/ — WiseGuyReports.Com Publish a New Market Research Report On –“ Personal Protective Equipment (PPE) Market To 2025 –Global Market Size, Development Status, Top Manufacturers, And Forecasts”.

Personal Protective Equipment (PPE) Market 2020

Description: –

The Personal Protective Equipment (PPE) industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Personal Protective Equipment (PPE) market size to maintain the average annual growth rate of 15 from xyz million $ in 2014 to xyz million $ in 2019, The analysts believe that in the next few years, Personal Protective Equipment (PPE) market size will be further expanded, we expect that by 2025, The market size of the Personal Protective Equipment (PPE) will reach xyz million $.

Get a Free Sample Report of Personal Protective Equipment (PPE) Market@ https://www.wiseguyreports.com/sample-request/5196705-global-personal-protective-equipment-ppe-market-report-2020

For more information or any query mail at sales@wiseguyreports.com

Key Players of Personal Protective Equipment (PPE) Market are:

Sievi
Cofra
Atlas
Ejendals
Aimont
Panda
Arbesko
Airtox
EMMA
Uvex

This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.

Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

The global Personal Protective Equipment (PPE) market is categorized into different types of products that are listed across various regions of the world. The key players handle the significant aspects of selling the products to the targeted consumers for attaining profitable outcome. The key players handle the major aspects such as manufacturing of the products, promoting the products and selling the products to the consumers. Hence, they are the sole reason for generating higher revenue by the end of the forecast period. The market is thriving with the increased demand that is managed by the key players. Without proper management of the demand requests, the market would eventually fall.

Along with that, the key players make sure to evolve the technologies of the products listed under the Personal Protective Equipment (PPE) market. Once the technologies are developed, the consumers will buy the products on priority to make sure that the sales rate increases in the long run. Along with that, the key players also develop the infrastructure to meet the rising demand rates with an ample amount of supply. People from different parts of the world are putting in maximum effort to get hold of these products for implementation onto their business operations. Thus, the global Personal Protective Equipment (PPE) market has a lot of happy consumers under their market circle, and the key players are doing their part to hold on to the reputation.

The report forecasts on the market growth and opportunities and also explains the potential of the market to deal with the market fluctuations. The report also focuses on the overall market segmentation based on different aspects such as application, end-user, product type and others. Along with that, it also highlights the regional classification where the market strength is judged based on the regional boundaries. The market size of the global Personal Protective Equipment (PPE) industry was massive in the previous forecast period, which is expected to increase beyond the predicted scales in the current forecast period 2020 to 2025. It is due to the increasing demand for the products listed under the global Personal Protective Equipment (PPE) market.

Personal Protective Equipment (PPE) Market Regional Analysis

The global Personal Protective Equipment (PPE) market is spread across various regions of the globe. Some of the popular areas where the key players are operating for the Personal Protective Equipment (PPE) market are North America, Europe, Asia-Pacific and South America. Out of these regions, North America is the most popular region that generated higher revenue in the previous forecast period and has the highest demand amongst other regions.

Enquiry About Personal Protective Equipment (PPE) Market @ https://www.wiseguyreports.com/enquiry/5196705-global-personal-protective-equipment-ppe-market-report-2020

Table of Contents – Major Key Points of Personal Protective Equipment (PPE) Market 2020

Section 1 Personal Protective Equipment (PPE) Product Definition

Section 2 Global Personal Protective Equipment (PPE) Market Manufacturer Share and Market Overview

Section 3 Manufacturer Personal Protective Equipment (PPE) Business Introduction

Section 4 Global Personal Protective Equipment (PPE) Market Segmentation (Region Level)

Section 5 Global Personal Protective Equipment (PPE) Market Segmentation (Product Type Level)

Section 6 Global Personal Protective Equipment (PPE) Market Segmentation (Industry Level)

Section 7 Global Personal Protective Equipment (PPE) Market Segmentation (Channel Level)

Section 8 Personal Protective Equipment (PPE) Market Forecast 2020-2025

Section 9 Personal Protective Equipment (PPE) Segmentation Product Type

Section 10 Personal Protective Equipment (PPE) Segmentation Industry

Continued…

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

NORAH TRENT
Wise Guy Reports
+1 628-258-0070
email us here


Source: EIN Presswire

Clinical Trials in Oncology: A Ray of Hope for Cancer Patients

Oncology Clinical Trials Training (OCTT)

DELHI, INDIA, December 3, 2020 /EINPresswire.com/ — Global cancer burden is on a rise and it is estimated that by the year 2030 there could be 27 million people with cancer translating to more than 17 million cancer deaths each year. Surgery, radiotherapy and chemotherapy have been used alone or in combinations with limited success. Scientific advancements in molecular biology and genetics of cells have triggered the discovery of novel approaches for an improved diagnosis as well as management of this disease. The various translational and targeted approaches for cancer management are being explored in the form of monoclonal antibodies, EGFR inhibitors, anti-angiogenesis, proteasome inhibitors, tyrosine kinase inhibitors, farnesyl transferase inhibitors, gene therapy and immunotherapy etc. CAR T-cell therapy, dendritic cell vaccine and antibody-drug conjugate (ADC) are newer forms of immunotherapy and targeted therapy approaches that are being explored for treating various cancers. While CAR T-cell uses specially altered T cells to fight cancer, dendritic cells help the immune system to recognize cancer cells and start an immune reaction against them. ADC on the other hand targets the tumour cells in order to specifically kill them leaving behind the healthy cells.

Clinical trials are the mainstay for bringing out newer, better and safe medicines to serve the mankind. Clinical trials are conducted in four different phases (I, II, III, and IV), where each phase is aimed at addressing a scientific question. While the initial safety of a new drug is established in Phase-I of clinical trial the later phases establishes the efficacy of the drug along with the safety. As clinical trials moves in a phase-wise manner, the next phase is initiated only if the drug passes the earlier phase. But clinical trials in oncology aren’t always easy to perform. Cancer patients have to volunteer, without knowing whether the new drug/therapy under development will benefit them or not. So how do we continue to advance cancer drug development through clinical trials? This can be achieved by knowing how to run safe and ethical clinical trials thereby protecting the rights, integrity and confidentiality of research subjects. A need of specific training and skills for conducting oncology clinical trials exists at the level of individual stakeholder.

The Oncology Clinical Trials Training (OCTT) course of Catalyst Clinical Services Pvt. Ltd. is aimed to equip the researchers with the knowledge and competencies required for carrying out oncology clinical trials. The duration of the course is 12 weeks and it provides a unique hands-on training opportunity for the monitoring of oncology clinical trials. Catalyst Clinical Services Pvt. Ltd., a leading clinical research organization and over the past 16 years more than 10,000 participants across 27 countries have enrolled for the various research training courses offered by Catalyst. For further details get in touch with the Program Coordinator at info@catalystclinicalservices.com

Block D1, Sector-16,
Catalyst Clinical Services Pvt. Ltd.
+91 9818356273
email us here


Source: EIN Presswire

Soft Gelatin Capsules (Softgels) Market 2020 – Global Sales,Price,Revenue,Gross Margin And Market Share

PUNE, MAHARASTRA, INDIA, December 3, 2020 /EINPresswire.com/ —

WiseGuyReports.Com Publish a New Market Research Report On –“ Soft Gelatin Capsules (Softgels) Market 2020 – Global Sales,Price,Revenue,Gross Margin And Market Share”.

Soft Gelatin Capsules (Softgels) Market 2020

Description: –

The Soft Gelatin Capsules (Softgels) industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Soft Gelatin Capsules (Softgels) market size to maintain the average annual growth rate of 15 from xyz million $ in 2014 to xyz million $ in 2019, The analysts believe that in the next few years, Soft Gelatin Capsules (Softgels) market size will be further expanded, we expect that by 2025, The market size of the Soft Gelatin Capsules (Softgels) will reach xyz million $.

Get a Free Sample Report of Soft Gelatin Capsules (Softgels) Market@ https://www.wiseguyreports.com/sample-request/5436600-global-soft-gelatin-capsules-softgels-market-report-2020

For more information or any query mail at sales@wiseguyreports.com

Key Players of Soft Gelatin Capsules (Softgels) Market are:

Catalent
Aenova
Nature's Bounty
Procaps
Patheon (Thermo Fisher Scientific)
IVC
EuroCaps
Captek
Strides Pharma Science
Lonza (Capsugel)
Soft Gel Technologies
Amway
Sirio Pharma
Baihe Biotech
Ziguang Group
Shineway
Donghai Pharm
By-Health
Yuwang Group
Guangdong Yichao

This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.

Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

The global Soft Gelatin Capsules (Softgels) market is categorized into different types of products that are listed across various regions of the world. The key players handle the significant aspects of selling the products to the targeted consumers for attaining profitable outcome. The key players handle the major aspects such as manufacturing of the products, promoting the products and selling the products to the consumers. Hence, they are the sole reason for generating higher revenue by the end of the forecast period. The market is thriving with the increased demand that is managed by the key players. Without proper management of the demand requests, the market would eventually fall.

Along with that, the key players make sure to evolve the technologies of the products listed under the Soft Gelatin Capsules (Softgels) market. Once the technologies are developed, the consumers will buy the products on priority to make sure that the sales rate increases in the long run. Along with that, the key players also develop the infrastructure to meet the rising demand rates with an ample amount of supply. People from different parts of the world are putting in maximum effort to get hold of these products for implementation onto their business operations. Thus, the global Soft Gelatin Capsules (Softgels) market has a lot of happy consumers under their market circle, and the key players are doing their part to hold on to the reputation.

The report forecasts on the market growth and opportunities and also explains the potential of the market to deal with the market fluctuations. The report also focuses on the overall market segmentation based on different aspects such as application, end-user, product type and others. Along with that, it also highlights the regional classification where the market strength is judged based on the regional boundaries. The market size of the global Soft Gelatin Capsules (Softgels) industry was massive in the previous forecast period, which is expected to increase beyond the predicted scales in the current forecast period 2020 to 2025. It is due to the increasing demand for the products listed under the global Soft Gelatin Capsules (Softgels) market.

Soft Gelatin Capsules (Softgels) Market Regional Analysis

The global Soft Gelatin Capsules (Softgels) market is spread across various regions of the globe. Some of the popular areas where the key players are operating for the Soft Gelatin Capsules (Softgels) market are North America, Europe, Asia-Pacific and South America. Out of these regions, North America is the most popular region that generated higher revenue in the previous forecast period and has the highest demand amongst other regions.

Enquiry About Soft Gelatin Capsules (Softgels) Market @ https://www.wiseguyreports.com/enquiry/5436600-global-soft-gelatin-capsules-softgels-market-report-2020

Table of Contents – Major Key Points of Soft Gelatin Capsules (Softgels) Market 2020

Section 1 Soft Gelatin Capsules (Softgels) Product Definition

Section 2 Global Soft Gelatin Capsules (Softgels) Market Manufacturer Share and Market Overview

Section 3 Manufacturer Soft Gelatin Capsules (Softgels) Business Introduction

Section 4 Global Soft Gelatin Capsules (Softgels) Market Segmentation (Region Level)

Section 5 Global Soft Gelatin Capsules (Softgels) Market Segmentation (Product Type Level)

Section 6 Global Soft Gelatin Capsules (Softgels) Market Segmentation (Industry Level)

Section 7 Global Soft Gelatin Capsules (Softgels) Market Segmentation (Channel Level)

Section 8 Soft Gelatin Capsules (Softgels) Market Forecast 2020-2025

Section 9 Soft Gelatin Capsules (Softgels) Segmentation Product Type

Section 10 Soft Gelatin Capsules (Softgels) Segmentation Industry

Continued…

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

NORAH TRENT
Wise Guy Reports
+162 825 80070
email us here


Source: EIN Presswire

Healthcare Contract Research Outsourcing Market 2020 Trends, Segmentation And Opportunities Forecasts To 2025

PUNE, MAHARASTRA, INDIA, December 3, 2020 /EINPresswire.com/ —

WiseGuyReports.Com Publish a New Market Research Report On –“ Healthcare Contract Research Outsourcing Market 2020 Trends, Segmentation And Opportunities Forecasts To 2025”.

Healthcare Contract Research Outsourcing Market 2020

Description: –

The Healthcare Contract Research Outsourcing industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Healthcare Contract Research Outsourcing market size to maintain the average annual growth rate of 15 from xyz million $ in 2014 to xyz million $ in 2019, The analysts believe that in the next few years, Healthcare Contract Research Outsourcing market size will be further expanded, we expect that by 2025, The market size of the Healthcare Contract Research Outsourcing will reach xyz million $.

Get a Free Sample Report of Healthcare Contract Research Outsourcing Market@ https://www.wiseguyreports.com/sample-request/5361477-global-healthcare-contract-research-outsourcing-market-report-2020

For more information or any query mail at sales@wiseguyreports.com

Key Players of Healthcare Contract Research Outsourcing Market are:

Charles River
Laboratory Corporation of America Holdings
IQVIA
Medpace
Pharmaceutical Product Development
Syneos Health
PAREXEL International Corporation
ICON plc
PRA Health Sciences
Envigo

This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.

Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

The global Healthcare Contract Research Outsourcing market is categorized into different types of products that are listed across various regions of the world. The key players handle the significant aspects of selling the products to the targeted consumers for attaining profitable outcome. The key players handle the major aspects such as manufacturing of the products, promoting the products and selling the products to the consumers. Hence, they are the sole reason for generating higher revenue by the end of the forecast period. The market is thriving with the increased demand that is managed by the key players. Without proper management of the demand requests, the market would eventually fall.

Along with that, the key players make sure to evolve the technologies of the products listed under the Healthcare Contract Research Outsourcing market. Once the technologies are developed, the consumers will buy the products on priority to make sure that the sales rate increases in the long run. Along with that, the key players also develop the infrastructure to meet the rising demand rates with an ample amount of supply. People from different parts of the world are putting in maximum effort to get hold of these products for implementation onto their business operations. Thus, the global Healthcare Contract Research Outsourcing market has a lot of happy consumers under their market circle, and the key players are doing their part to hold on to the reputation.
The report forecasts on the market growth and opportunities and also explains the potential of the market to deal with the market fluctuations. The report also focuses on the overall market segmentation based on different aspects such as application, end-user, product type and others. Along with that, it also highlights the regional classification where the market strength is judged based on the regional boundaries. The market size of the global Healthcare Contract Research Outsourcing industry was massive in the previous forecast period, which is expected to increase beyond the predicted scales in the current forecast period 2020 to 2025. It is due to the increasing demand for the products listed under the global Healthcare Contract Research Outsourcing market.

Healthcare Contract Research Outsourcing Market Regional Analysis

The global Healthcare Contract Research Outsourcing market is spread across various regions of the globe. Some of the popular areas where the key players are operating for the Healthcare Contract Research Outsourcing market are North America, Europe, Asia-Pacific and South America. Out of these regions, North America is the most popular region that generated higher revenue in the previous forecast period and has the highest demand amongst other regions.

Enquiry About Healthcare Contract Research Outsourcing Market @ https://www.wiseguyreports.com/enquiry/5361477-global-healthcare-contract-research-outsourcing-market-report-2020

Table of Contents – Major Key Points of Healthcare Contract Research Outsourcing Market 2020

Section 1 Healthcare Contract Research Outsourcing Product Definition

Section 2 Global Healthcare Contract Research Outsourcing Market Manufacturer Share and Market Overview

Section 3 Manufacturer Healthcare Contract Research Outsourcing Business Introduction

Section 4 Global Healthcare Contract Research Outsourcing Market Segmentation (Region Level)

Section 5 Global Healthcare Contract Research Outsourcing Market Segmentation (Product Type Level)

Section 6 Global Healthcare Contract Research Outsourcing Market Segmentation (Industry Level)

Section 7 Global Healthcare Contract Research Outsourcing Market Segmentation (Channel Level)

Section 8 Healthcare Contract Research Outsourcing Market Forecast 2020-2025

Section 9 Healthcare Contract Research Outsourcing Segmentation Product Type

Section 10 Healthcare Contract Research Outsourcing Segmentation Industry

Continued…

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

NORAH TRENT
Wise Guy Reports
+162 825 80070
email us here


Source: EIN Presswire